NCT05652179

SGB Reduces the Incidence and Severity of CSA-AKI

Pretreatment with Stellate Ganglion Block Reduces the Incidence and Severity of Cardiac Surgery-Associated Acute Kidney Injury

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 396 (actual)
• Sponsor: Yangzhou University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

The incidence of acute kidney injury after cardiopulmonary bypass cardiac surgery is high, which increases postoperative mortality and is not conducive to the prognosis of patients. Stellate ganglion blocks increase renal blood flow, reduce inflammation and stress, and protect the heart muscle. In this study, stellate ganglion block was used to promote rapid recovery of kidney function after cardiopulmonary bypass cardiac surgery.

Conditions

• Stellate Ganglion Block

Interventions

Type	Name	Description
DRUG	Stellate ganglion block	After the induction of general anesthesia and before the start of the surgery,ultrasound-guided stellate ganglion block is performed, injecting 5 ml of 0.375% ropivacaine.

Timeline

• Start date: 2023-01-10
• Primary completion: 2023-12-01
• Completion: 2023-12-30
• First posted: 2022-12-15
• Last updated: 2025-01-23

Locations

1 site across 1 country: China